Saamya Biotech India informs about quarterly statement of investor complaints

06 Apr 2016 Evaluate

Saamya Biotech India has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1432.80
Dr. Reddys Lab 5751.70
Cipla 1465.65
Zydus Lifesciences 1005.90
Lupin 1567.65
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.